First Results For Phase IIa Data Of UCB's Lacosamide For Treatment Of Fibromyalgia UCB announced headline results based on first-line analyses of its Phase IIa clinical trial with lacosamide to treat fibromyalgia syndrome. The initial results from this proof of concept study showed activity of lacosamide in fibromyalgia syndrome but require further analysis. A decision to start Phase IIb will be made by the end of the year.
Source: www.medicalnewstoday.comSavings Help The Medicine Go Down A new study of state-subsidized pharmacy assistance programs showed that providing
prescription drug coverage for low-income seniors reduces Medicaid and Medicare costs. Moreover, needy seniors enrolled in the programs were able to cut their dose skimping and nursing home admissions in half, according to the Brandeis University research.In 2002, Illinois and Wisconsin implemented state pharmacy assistance programs with joint federal funding.
Source: www.medicalnewstoday.comNew Study Finds Oral Cannabis Ineffective In Treating Acute Pain A study published in the July issue of the Journal Anesthesiology discovered that oral cannabis (a form of medical marijuana) not only failed to alleviate certain types of pain in human volunteers but, surprisingly, it instead caused increased sensitivity to some forms of pain.In their research, Birgit Kraft, M.D.
Source: www.medicalnewstoday.comMozambique Business Association Launches Program That Aims To Address HIV/AIDS In Workplaces The Confederation of Business Associations in Mozambique recently launched a program called ECOSIDA to address issues related to HIV/AIDS in the workplace, SAPA/iAfrica.com reports.
Source: www.medicalnewstoday.com
# posted by Network @ 3:00 PM
